The correlation between leptin and highly sensitive C-reactive protein levels in obese children aged 9-15 years
Background Obesity is a low level and chronic inflammatory condition predominantly affecting white adipose tissue, where macrophage infiltration is found. Leptin is one of many molecules relating obesity to cardiovascular disease. Leptin can increase cytokine production in macrophages and monocytes, and increase oxidative stress on endothelial cells. Pro-inflammatory cytokines, in turn, may trigger the release of C-reactive protein.
Objective To examine the correlation between leptin and hsCRP in obese children aged 9-15 years.
Methods This cross-sectional study was done in Manado from May to December 2009, on elementary and junior high school children. Subjects were obese children aged 9-15 years, with nutritional status detennined by Body Mass Index and converted into z-score. Physical examination, blood pressure, and blood examinations for Â fasting blood sugar (FBS), lipid profile, leptin, and hsCRP were perfonned. Data were analyzed with appropriate statistical methods.
Results The mean leptin level in obese children was 34,009.2 pgiL (SD 18,224.79), higher than that of the control, 7,760.9 pgiL (SD 8,859.55) (P<0.0001). The mean hsCRP level in obese children was 3.6 mgiL (SD 3.60), higher than that of the control, 0.7 mgiL (SD 1.32) (<0.0001). There was a significant positive correlation between leptin and hsCRP levels in obese children (r ô€€ 0.355; P<0.0001).
Conclusions There is significant positive correlation between leptin and hsCRP levels in obese children aged 9-15 years. Increased leptin and hsCRP levels indicate a low degree of chronic inflammation. Thus, intervention is needed to decrease the body weight of obese children.
2. Dubey L, Hesong Z. Role of leptin in atherogenesis. Exp Clin Cardiol. 2006;269-75.
3. Sastroasmoro S, Ismael S. Dasar-dasar metodologi penelitian klinis. Jakarta: Sagung Seto; 2002. p. 280.
4. Wolff C, Hoang S, Flannery D, Wennuth L. A preliminary study of diet, overweight, elevated blood pressure, and acanthosis nigricans among Kô€™9th grade Native American students. Californian J Health Promot. 2006;4:77-87.
5. Ikezaki A, Miura N, Kikuoka N. Clinical characteristics of obese Japanese children 'With acanthosis nigricans. Clin Pediatr Endocrino!. 2001; 10:47-52.
6. Steinbeck K. Childhood obesity: consequences and physical and psychosocial complications. In: Kopelman PG, Caterson ID, Dietz WH, editors. Clinical obesity in adults and children. Massachusetts: Blackwell Publishing; 2005. p. 231-48.
7. Ledennan SA, Akabas SR, Moore BJ. Summary of the presentations at the conference on preventing childhoodobesity. Pediatrics. 2004; 114:1146-73.
8. Hendarto A. Telaah peran leptin, adiponektin, tumor necrosis factoHl, C reactive protein, asupan karbohidrat dan lemak terhadap resistensi insulin pada anak lelaki superobes usia 5-9 tahun. [dissertation]. [Jakarta (Indonesia)]: University of Indonesia Medical School; 2009.
9. Punthakee Z, Delvin EE, Paradis G, Levy E, Plat RW, Lambert M. Adiponectin, adiposity, and insulin resistance in children and adolescents. J Clin Endocrinol Metab. 2006;91:2119-25.
10. Schiel R, Beltschikow W, Kramer G, Stein G. Overweight, obesity and elevated blood pressure in children and adolescents. EurJ Med Res. 2006;11:97-101.
11. Barath A, Boda K, Tichy M, Karoly Â£, Turi S. International comparison ofblooo pressure and BMI values in schoolchildren aged 11-16 years. Acta Paediatr. 2010;99:251-5.
12. Fox MD, Aficme A, Studebaker Ij, Wei T, Hellman CM. The prevalence of elevated blood pressure among obese adolescents in a pediatric resident continuity clinic. J Okla State Med Assoc. 2010;103:111-4.
13. Valle M, Martos R, Gascon F, Canete R, Zafra MA, Morales R. Low-grade systemic inflammation, hypoadinopectinemia and a high concentration of leptin are present in very young obese children, and correlate 'With metabolic syndrome. Diabetes Metab. 2005;31:55-62.
14. Diamond FB Jr, Cuthbertson D, Hanna S, Eichler D. Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J Pediatr Endocrinol Metab. 2004; 17:1069-75.
15. Reinehr T, Stoffel-Wagner B, Roth CL, Andler W. Highsensitive C-reactive protein, tumor necrosis factor alpha,and cardiovascular risk factors before and after weight loss in obese children. Metabolism. 2005;54:115 5-61.
16. Kapiotis S, Holzer G, Schaller G, Haumer M, Widhalm H, Weghuber D. A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler T hromb Vasc BioI. 2006;26,2541-6.
17. Wu DM, Chu NF, Shen MH, Wang SC. Obesity, plasma high sensitivity C
reactive protein levels and insulin resistance status among school children in Taiwan. Clin Biochem. 2006;39,810-5.
18. Yoshida T, Kaneshi T, Shimabukuro T, Sunagawa M, Ohta T. Serum C-reactive protein and its relation to cardiovascular risk factors and adipocytokines in Japanese children. J Clin Endocrinol Metab. 2006;91:2133-7.
19. Oliveira AC, Oliveira AM, Adan LF, Oliveira NF, Silva AM, Ladeia AM. C-reactive protein and metabolic syndrome in youth: a strong relationship? Obesity. 2008; 16:1094-8.
20. Mattsson N, Ronnemaa T, J uonala M, Viikari JS, Raitakari OT. Childhood predictors of the metabolic syndrome in adulthood. T he Cardiovascular Risk in Young F inns Study. Ann Med. 2008;40:542-52.
21. Li CW,jiang DL, Qiao J, SunJM, HuangJp, Chen HP, Zhu H. Changes of leptin resistance, blood lipids and inflammatory response before and after the exercise therapy in children 'With obesity. Zhongguo Dang Dai Er Ke Za Zhi. 2010;12:40-2.
22. Lyon CJ, Law, Hsuch W A. Minireview: adiposity, inflammation and atherogenesis. Endocrinology. 2003; 144:2195-200.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.